This paper explores the issue of purchasing cost savings in health insurance mergers and whether they should be considered to be procompetitive efficiencies or an exercise of monopsony power. This issue arose in the United States v. Anthem (D.D.C.) litigation, and the authors explain how each side and the courts addressed this issue. Click here to read the full article.